|This is the talk page for discussing improvements to the Everolimus article.|
|Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Everolimus.
|WikiProject Pharmacology||(Rated Start-class)|
Please, I work with transplats persons I will receive more information about the best therapy, sirolimus or verlimus, and if you have a comparative study betwen these two medications.
Thanks This page is very helpfull. firstname.lastname@example.org
I believe that there is an error in the structure shown for everolimus. I believe that the methyl group on the ethylene bridge between the lactone and the cyclohexyl ring should be in the R configuration (solid wedge).
- Yes, you're right. I'll correct the structure as soon as possible. Fvasconcellos (t·c) 16:10, 24 December 2009 (UTC)
Need more on Kidney cancer
Novartis investigating use as anti-aging drug
". . . Novartis has completed a successful pilot trial examining its cancer drug everolimus as a potential treatment to reverse immunosenescence, or the gradual deterioration of the immune system that occurs with age and is a major cause of disease and death."
(Similar content appeared in the Baltimore Sun for 11/13/2014 in an article headlined "Drugmakers look to push bounds of aging." Couldn't find that online 11/13; sometimes articles from the Sun are posted online a couple of days after their appearance in the hard-copy newspaper.)